Involvement of the Septal Nuclei of the Human Brain in Alcohol Use Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-65
SponsorAnders Fink-Jensen, MD, DMSci

About this trial

Alcohol activates reward systems in different brain areas, i.e., the nucleus accumbens, dorsal striatum, extended amygdala, and prefrontal cortex. These areas are all part of the reward neurocircuitry, which plays an important role in the development of addiction.

A former study performed on rodents has shown that a specific area of the forebrain, the septal nuclei, is associated with the feeling of reward and, hence, addiction when stimulated. However, whether the septal area is involved in reward and addiction in humans is sparsely investigated.

The purpose of this brain-imaging study is to assess how the septal nuclei react to alcohol-related pictures shown to participants diagnosed with alcohol use disorder while lying in an MRI scanner, compared to people without a diagnosis of alcohol use disorder. This might give us a better understanding of how the septal nuclei is involved in reward and addiction.

Eligibility criteria

Qualifiers

Diagnosed with alcohol use disorder (AUD) according to DSM-5, and alcohol dependence according to ICD-10

An Alcohol Use Disorder Identification Test (AUDIT) score ≥ 15

At least six heavy drinking days for the last 30 days, measured with the Time Line Follow Back (TLFB) method

Disqualifiers

Diagnosis of schizophrenia spectrum disorder, paranoid psychosis, bipolar disorder, or mental retardation

Previous or current substance use disorder other than AUD and nicotine use disorder

History of alcohol withdrawal seizures within the past 5 years

Alcohol withdrawal symptoms defined as a CIWA-Ar score > 9 at screening or at the fMRI session

Trial design

Treatments tested in this trial

  • Brain imaging

Treatment groups

25 Participants
are divided into 1 treatment group

Sponsors and collaborators

Anders Fink-Jensen, MD, DMSci

Lead sponsor

Psychiatric Centre Rigshospitalet

Sponsor institution

Neurobiology Research Unit, Rigshospitalet

Collaborator

The foundation of Mr. Ivan Nielsen

Collaborator

King Christian X foundation

Collaborator